- CVS Health launches new brand Cordavis to target $100 billion biosimilar market Yahoo Finance
- CVS Health launches subsidiary to produce biosimilar drugs CNBC Television
- CVS pushes into making cheaper versions of complex drugs with new discount Humira CNBC
- CVS launches new brand targeting biosimilar market Yahoo Finance
- CVS Unveils Cordavis to Offer Biosimilars. Should AbbVie (NYSE:ABBV) Worry? - TipRanks.com TipRanks
- View Full Coverage on Google News
Thursday, August 24, 2023
CVS Health launches new brand Cordavis to target $100 billion biosimilar market - Yahoo Finance
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment